Evening Symposium: Mucosal Healing as the Goal for Crohn’s Disease Treatment: Discovering Strategies for Therapeutic Success

Evening Symposium: Mucosal Healing as the Goal for Crohn’s Disease Treatment: Discovering Strategies for Therapeutic Success

National Meeting
Program Details

Registration for the symposium is now available. 

A Saturday Satellite Symposium at the ACG 2019 Annual Scientific Meeting

Grand Hyatt San Antonio
Meeting Room:  Texas Ballroom DE, Fourth Floor
600 East Market Street
San Antonio, Texas

October 26, 2019

7:30 PM - 8:00 PM, Registration and Complimentary Lunch Buffet
8:00 PM - 9:30 PM, Interactive Symposium and Q&A Session

This event is neither sponsored by nor endorsed by ACG.

Faculty

Faculty

Russell D. Cohen, MD FACG
University of Chicago
Chicago, IL

Miguel D. Regueiro, MD
Digestive Disease and Surgery Institute at Cleveland Clinic
Cleveland, Ohio

Corey A. Siegel, MD, MS
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire

Intended Learners

Gastroenterology physicians, fellows, and related healthcare providers attending ACG 2019

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Review the evidence in support of MH as a primary goal of CD treatment 
  • Discuss strategies to define, monitor, and achieve MH in patients with moderate-to-severe CD
  • Evaluate the clinical trial data and RWE surrounding the impact of available biologics on MH induction and maintenance for optimal therapeutic positioning
Activity Overview

To encourage clinician participation, maximize learner and speaker interaction, and assess the
assimilation of knowledge for application to competence and performance by participants, the satellite
symposium will incorporate an interactive Audience Response System (ARS) for real-time audience
participation and feedback. Utilizing the ARS, the session will include pre- and post-activity assessment
questions, embed in-presentation polling questions, capture audience questions in real time, include
case studies, and allow ample time for discussion and audience Q&A to ensure a balance of expertdriven
and learner-directed education. All participant feedback will be captured and downloaded as part
of the outcomes assessment.

 

Accreditation

 Imedex is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Planning Committee

Imedex®, LLC, is accredited by the ACCME to provide continuing medical education for physicians.
In support of improving patient care, this activity has been planned and implemented by the North

American Center for Continuing Medical Education (NACCME) and Imedex. NACCME is jointly accredited
by ACCME, ACPE, and ANCC to provide continuing education for the healthcare team.

Financial Disclosure and Conflicts of Interest

 

Imedex use a multifaceted approach to identify and secure faculty for all CME/CE initiatives, including a
review of current literature and discussions with current and previous faculty contributors and
educational partners. The objective is to ensure that all faculty contributors have an appropriate level of
expertise in the therapeutic area and with the target audience, an understanding of adult-learning
principles, and that all potential conflicts of interest are disclosed and resolved.
Imedex is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all of its
CME/CE activities. Imedex requires all potential faculty members and program planners, in advance, to
disclose financial relationships with relevant commercial interests. Imedex uses that information to
determine whether prospective contributors have potential conflicts of interest. If significant
relationships are disclosed, Imedex will assess how those potential conflicts of interest may affect
CME/CE content. Imedex requires faculty members to validate all treatment recommendations by
stating the level of evidence and requires all content to be reviewed by an independent clinical reviewer
before dissemination. If Imedex and the reviewer agree that data are biased, do not represent accepted
standards of US medical practice, and/or do not conform to research principles accepted by the
scientific community, contributors must exclude those data or not be permitted to present. Imedex is
committed to resolving potential conflicts of interest, although if contributors have significant
relationships that cannot be reconciled, Imedex reserves the right to prohibit participation. All Imedex
activities are developed in accordance with the ACCME “Essentials and Standards for Commercial
Support,” as well as ACPE, ACCN, PhRMA, FDA, AMA, OIG, and other relevant regulatory guidelines.

Hardware/Software Requirements

The evaluation is accessible after the activity via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

ADA Statement

North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137. 

Grant Support

The following company has provided an educational grant in support of this symposium:
Takeda Pharmaceuticals U.S.A, Inc.

Privacy Policy

Imedex protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Imedex and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.